Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Lassen

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Scandinavian Journal of Primary Health Care|March 1, 1997
C-reactive protein in general practice--how commonly is it used and why?B S Dahler-Eriksen, J F Lassen, E D Lund, et al.
Clinical Chemistry|April 2, 1999
Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomesB S Dahler-Eriksen, T Lauritzen, J F Lassen, et al.
Ugeskrift for Laeger|November 11, 1996
[Resistance to activated protein C. The most common cause of familial thrombophilia]T B Larsen, H B Ravn, J F Lassen, et al.
Ugeskrift for Laeger|September 19, 1998
[Differences in the use of C-reactive protein analysis and erythrocyte sedimentation in general practice and hospitals. Development from 1986 to 1995]B S Dahler-Eriksen, J F Lassen, T Lauritzen, et al.
Journal of Internal Medicine|May 19, 2004
The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarctionE L Grove, T F Ørntoft, J F Lassen, et al.
Scandinavian Journal of Primary Health Care|February 2, 2002
HbAlc in an unselected population of 4438 people with type 2 diabetes in a Danish countyJ K Kristensen, F Bro, A Sandbaek, et al.
Thrombosis Research|December 5, 1998
Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutationT B Larsen, J F Lassen, B S Dahler-Eriksen, et al.
Thrombosis Research|June 30, 1998
The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newbornsT B Larsen, J F Lassen, I Brandslund, et al.
Clinical Chemistry|November 20, 1997
Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plotsB S Dahler-Eriksen, J F Lassen, P H Petersen, et al.
Thrombosis Research|March 14, 2000
Evaluation of a simple dosage scheme for transition from phenprocoumon to warfarin in oral anticoagulationC Kristiansen, J F Lassen, B S Dahler-Eriksen, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Primary Health Care|March 1, 1997
C-reactive protein in general practice--how commonly is it used and why?B S Dahler-Eriksen, J F Lassen, E D Lund, et al.
Clinical Chemistry|April 2, 1999
Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomesB S Dahler-Eriksen, T Lauritzen, J F Lassen, et al.
Ugeskrift for Laeger|November 11, 1996
[Resistance to activated protein C. The most common cause of familial thrombophilia]T B Larsen, H B Ravn, J F Lassen, et al.
Ugeskrift for Laeger|September 19, 1998
[Differences in the use of C-reactive protein analysis and erythrocyte sedimentation in general practice and hospitals. Development from 1986 to 1995]B S Dahler-Eriksen, J F Lassen, T Lauritzen, et al.
Journal of Internal Medicine|May 19, 2004
The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarctionE L Grove, T F Ørntoft, J F Lassen, et al.
Scandinavian Journal of Primary Health Care|February 2, 2002
HbAlc in an unselected population of 4438 people with type 2 diabetes in a Danish countyJ K Kristensen, F Bro, A Sandbaek, et al.
Thrombosis Research|December 5, 1998
Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutationT B Larsen, J F Lassen, B S Dahler-Eriksen, et al.
Thrombosis Research|June 30, 1998
The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newbornsT B Larsen, J F Lassen, I Brandslund, et al.
Clinical Chemistry|November 20, 1997
Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plotsB S Dahler-Eriksen, J F Lassen, P H Petersen, et al.
Thrombosis Research|March 14, 2000
Evaluation of a simple dosage scheme for transition from phenprocoumon to warfarin in oral anticoagulationC Kristiansen, J F Lassen, B S Dahler-Eriksen, et al.
Pageof 6